The frameless CyberKnife® design, multiple fractionation capability, and virtually unlimited dose-coverage capability compared with Gamma Knife indicates a much larger spectrum of applicability to recurrent head and neck lesions with CyberKnife®.
Case Studies:
Left Optic Nerve Meningioma (WHO Grade 2)
Barrow Neurological Institute
Meningioma (Optic Chiasm)
Stanford University Medical Center
See Also:
Recurrent Head & Neck Cancers
Images adapted from
"Robotic Radiosurgery" - First Edition

Written by Donald B. Fuller, M.D. – Radiation Oncologist